Genpact director granted 6,521 restricted shares

Genpact Limited director Brian Mark Stevens received an equity award in the form of restricted share units.

Rhea-AI Filing Summary

Genpact Limited director Brian Mark Stevens received an equity award in the form of restricted share units. He acquired 6,521 common shares at a price of $0.00 per share through a grant classified as a non-derivative award. Following this award, his direct holdings increased to 36,619 common shares.

The grant represents unvested restricted share units (RSUs) under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles him to one common share. Subject to his continued service, the RSUs will fully vest on December 31, 2026 and will be settled in common shares on December 31, 2027.

Insider Trade Summary

Grant/Award: 6,521 shares

Grant/Award 1 txn

Insider STEVENS BRIAN MARK

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Shares	6,521	$0.00	$0.00

Holdings After Transaction: Common Shares — 36,619 shares (Direct)

Footnotes (1)

1. F1. Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2026 and will be settled in common shares on December 31, 2027.

Key Figures

RSU grant size: 6,521 shares Grant price: $0.00 per share Post-transaction holdings: 36,619 shares +2 more

5 metrics

RSU grant size 6,521 shares Common shares acquired via grant on April 23, 2026

Grant price $0.00 per share Equity compensation award, not open-market purchase

Post-transaction holdings 36,619 shares Total direct common shares after grant

Vesting date December 31, 2026 RSUs fully vest subject to continued service

Settlement date December 31, 2027 RSUs settled in common shares one year after vest

Key Terms

restricted share units (RSUs), 2017 Omnibus Incentive Compensation Plan, vest, settled in common shares

4 terms

restricted share units (RSUs) financial

"Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan."

Restricted share units (RSUs) are a form of employee pay where a company promises to give shares (or their cash value) to workers after certain conditions, usually time or performance, are met. For investors, RSUs matter because they can increase the number of shares outstanding and signal how management is being paid and incentivized—think of them as delayed bonuses that convert into ownership when vesting conditions are satisfied.

2017 Omnibus Incentive Compensation Plan financial

"granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan."

vest financial

"Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2026"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

settled in common shares financial

"and will be settled in common shares on December 31, 2027."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Genpact (G) director Brian Mark Stevens report in this Form 4?

Brian Mark Stevens reported an equity grant of 6,521 common shares via restricted share units. The award was made at $0.00 per share and increased his direct holdings to 36,619 Genpact common shares after the transaction.

How many Genpact (G) shares did Brian Mark Stevens acquire and at what price?

He acquired 6,521 Genpact common shares through a grant transaction priced at $0.00 per share. This reflects a compensation-related award, not an open-market purchase, and classifies as a grant, award, or other acquisition under Form 4 rules.

What type of equity award did Genpact (G) grant to Brian Mark Stevens?

Genpact granted unvested restricted share units (RSUs) under its 2017 Omnibus Incentive Compensation Plan. Each RSU entitles him to receive one common share at a future date, subject to vesting and continued service conditions described in the footnote.

When will Brian Mark Stevens’ Genpact (G) RSUs vest and settle?

The RSUs will fully vest on December 31, 2026, subject to his continued service. They will then be settled in common shares on December 31, 2027, meaning the actual share delivery occurs one year after vesting, assuming conditions are met.

How many Genpact (G) shares does Brian Mark Stevens hold after this award?

After the grant, he directly owns 36,619 Genpact common shares according to the Form 4. This total includes the newly awarded shares associated with the RSU grant and reflects his direct ownership position following the reported transaction.

Is Brian Mark Stevens’ Genpact (G) transaction a market buy or a compensation grant?

The transaction is a compensation-related grant, not a market buy. It is coded as an “A” transaction, described as a grant, award, or other acquisition, with a per-share price of $0.00, consistent with equity awards under an incentive compensation plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/27/2026 - 04:24 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

STEVENS BRIAN MARK

(Last) (First) (Middle)

C/O GENPACT LLC

521 FIFTH AVENUE, 14TH FLOOR

(Street)

NEW YORK NEW YORK 10175

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Genpact LTD [ G ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	04/23/2026		A		6,521(1)	A	$0	36,619	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2026 and will be settled in common shares on December 31, 2027.

Remarks:

	/s/ Thomas D. Scholtes, as Attorney-in-fact for Brian Mark Stevens	04/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)